We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

Corey Bakalarski - Principal Scientist, Bioinformatics, Microchemistry, Proteomics, Lipidomics and Next-Generation Sequencin

Corey Bakalarski

Principal Scientist, Bioinformatics, Microchemistry, Proteomics, Lipidomics and Next-Generation Sequencin

13
Years at Genentech
10
Publications
2
Awards & Honors

I started my graduate work at Harvard Medical School while bioinformatics and computational biology were still emerging fields, intrigued by the potential of genomics to answer fundamental questions of science and disease. Instead, I found myself engrossed in the even more nascent field of proteomics, which held the additional promise of a direct understanding of the complex world of protein interactions which guide the cell but are only hinted at in its DNA.

However, much work remained to be done to develop the computational methods necessary to make biological sense of the raw, numerical data. It was here that I discovered my passion for the engineering necessary to create the systems that power our new -omics driven world, and to do so with the throughput necessary to drive today’s science. At Genentech, my group develops the new algorithms necessary to analyze data from cutting-edge proteomic and related analytical methods and the data platforms necessary to analyze, organize, and visualize this data at scale.

Featured Publication

Rapid, semi-automated protein terminal characterization using ISDetect.

Nat Biotechnol. 2016 Aug 9;34(8):811-3.

Bakalarski CE, Gan Y, Wertz I, Lill JR, Sandoval W.